Clinical Trials List
Protocol NumberCLEE011X2108
2014-04-01 - 2019-12-31
Phase I/II
Terminated1
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 林季宏 Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
220 participants
